Imiquimod 5% cream in occlusion, for the treatment of lentigo maligna: A new scheme of short cycles and the need for clinical trials

Dermatol Ther. 2019 Jan;32(1):e12757. doi: 10.1111/dth.12757. Epub 2018 Nov 4.

Stefano Astorino^{1

2}, Paolo Astorre³, Paola Pasquini⁴, Donato Di Nunno^{1

2}, Federico Pellegrini³, Giovanni Paolino^{5

6}

¹ Dermatology and Venereology, Celio Military Hospital, Rome, Italy.
² Department of Internal Medicine, Celio Military Hospital, Rome, Italy.
³ Department of Oncology, Celio Military Hospital, Rome, Italy.
⁴ Service of Surgical Pathology, Celio Military Hospital, Rome, Italy.
⁵ Unit of Dermatology, IRCCS University Vita-Salute San Raffaele, Milan, Italy.
⁶ Department of Dermatology, Dipartimento di Medicina Interna e Specialità Mediche, La Sapienza University of Rome, Rome, Italy.

No abstract available

Publication types